Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Queensland Health
Chubb
Citi
Healthtrust
Dow
Julphar
Farmers Insurance

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090924

« Back to Dashboard

NDA 090924 describes IBUTILIDE FUMARATE, which is a drug marketed by Luitpold and Mylan Institutional and is included in three NDAs. It is available from one supplier. Additional details are available on the IBUTILIDE FUMARATE profile page.

The generic ingredient in IBUTILIDE FUMARATE is ibutilide fumarate. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.
Summary for 090924
Tradename:IBUTILIDE FUMARATE
Applicant:Mylan Institutional
Ingredient:ibutilide fumarate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.1MG/ML
Approval Date:Jan 11, 2010TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Accenture
Citi
Argus Health
Cipla
Daiichi Sankyo
Fuji
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.